Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Whether weight applies to your situation is a determination your prescribing provider makes
Methods Diet-induced obesity was treated with tirzepatide or vehicle for 25 days
Quick Takeaways Tirzepatide is a dual GIP/GLP-1 receptor agonist with clinically proven weight loss and metabolic benefits and significant results have been documented at the approved starting dose of 2.5 mg weekly The dosing range for Tirzepatide is 2.515 mg weekly
A safety population comprised all women who received at least one dose of the assigned treatment
US$ 22.59
US$ 28.42
US$ 26.47
US$ 28.56
US$ 29.74
US$ 20.24
![Espeon (1/75) [Neo Discovery Unlimited] Alara](https://cdn.shopify.com/s/files/1/0266/9513/9533/files/b98ba970-3065-4fb5-9701-a0a1fd13d10b.jpg?v=1774823422)
